Digital Biomarkers Study Explores Cognitive Decline Prediction Using Wearable Technology in Memory Clinic Patients

References

1. 1.Australian Government Department of Health. (2023). National Dementia Strategy. Department of Health. https://www.health.gov.au/our-work/national-dementia-strategy
2. 2.Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015). Amyloid biomarkers in Alzheimer's disease. Trends in Pharmacological Sciences, 36(5), 297-309. https://doi.org/10.1016/j.tips.2015.03.002
3. 3.Cummings, J., Lee, G., Ritter, A., Sabbagh, M., & Zhong, K. (2019). Alzheimer's disease drug development pipeline: 2019. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 5, 272-293. https://doi.org/10.1016/j.trci.2019.05.008
4. 4.Dagum, P. (2018). Digital biomarkers of cognitive function. NPJ Digital Medicine, 1(1), 10. https://doi.org/10.1038/s41746-018-0018-4
5. 5.Eysenbach, G. (2005). The law of attrition. Journal of Medical Internet Research, 7(1), e11. https://doi.org/10.2196/jmir.7.1.e11
6. 6.Golde, T. E., DeKosky, S. T., & Galasko, D. (2018). Alzheimer's disease: The right drug, the right time. Science, 362(6420), 1250-1251. https://doi.org/10.1126/science.aau0437
7. 7.Goldsack, J. C., Coravos, A., Bakker, J. P., Bent, B., Dowling, A. V., Fitzer-Attas, C., Godfrey, A., Godino, J. G., Gujar, N., Izmailova, E., Manta, C., Peterson, B., Vandendriessche, B., Wood, W. A., Wang, K. W., & Dunn, J. (2020). Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs). NPJ Digital Medicine, 3(1), 55. https://doi.org/10.1038/s41746-020-0260-4
8. 8.Jack Jr, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., & Sperling, R. (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia, 14(4), 535-562. https://doi.org/10.1016/j.jalz.2018.02.018
9. 9.Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019). Digital biomarkers for Alzheimer's disease: the mobile/wearable devices opportunity. NPJ Digital Medicine, 2(1), 9. https://doi.org/10.1038/s41746-019-0084-2
10. 10.Matcham, F., Barattieri di San Pietro, C., Bulgari, V., de Girolamo, G., Dobson, R., Eriksson, H., Folarin, A. A., Haro, J. M., Kerz, M., Lamers, F., Li, Q., Manyakov, N. V., Mohr, D. C., Myin-Germeys, I., Narayan, V., Bwayo, D., Ranjan, Y., Rashid, Z., Rintala, A., Siddi, S., Simblett, S., Wykes, T., Hotopf, M., & RADAR-CNS consortium. (2019). Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol. BMC Psychiatry, 19(1), 72. https://doi.org/10.1186/s12888-019-2049-z
11. 11.Nebeker, C., Torous, J., & Ellis, R. J. (2019). Building the case for actionable ethics in digital health research supported by artificial intelligence. BMC Medicine, 17(1), 137. https://doi.org/10.1186/s12916-019-1377-7
12. 12.Pratap, A., Neto, E. C., Snyder, P., Stepnowsky, C., Elhadad, N., Grant, D., Mohebbi, M. H., Mooney, S., Suver, C., Wilbanks, J., Mangravite, L., Heagerty, P. J., Areán, P., & Omberg, L. (2019). Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants. NPJ Digital Medicine, 2(1), 26. https://doi.org/10.1038/s41746-019-0093-1
13. 13.Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack Jr, C. R., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., & Phelps, C. H. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups. Alzheimer's & Dementia, 7(3), 280-292. https://doi.org/10.1016/j.jalz.2011.03.003
14. 14.University College London. (2024). Predictors Of Cognitive Decline In Attenders Of Essex Memory Clinic From Digital Devices Using Classical Statistical Methods, Machine Learning And Disease Progression Modelling. ClinicalTrials.gov. NCT07051408. https://clinicaltrials.gov/study/NCT07051408
15. 15.World Health Organization. (2023). Dementia Fact Sheet. WHO Media Centre. https://www.who.int/news-room/fact-sheets/detail/dementia